1. Invited Commentary

   • Andres Cárdenas
   • Vicente Arroyo

   OriginalPaper Pages: 1 - 4

2. Web alert

   News Pages: 5 - 6

3. Literature alert

   Abstract Pages: 7 - 9

4. Clinical trials report

   • Bruce R. Bacon

   BriefCommunication Pages: 13 - 14

5. The HCV and HIV coinfected patient: What have we learned about pathophysiology?

   • Andrew H. Talal
   • P. Wilfredo Canchis
   • Ira M. Jacobson

   OriginalPaper Pages: 15 - 22

6. Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

   • Markus Cornberg
   • Heiner Wedemeyer
   • Michael P. Manns

   OriginalPaper Pages: 23 - 30

7. Evolving pathophysiologic concepts in nonalcoholic steatohepatitis

   • Brent A. Neuschwander-Tetri

   OriginalPaper Pages: 31 - 36

8. Use of ursodeoxycholic acid in patients with liver disease

   • Paul Angulo

   OriginalPaper Pages: 37 - 44

9. Primary biliary cirrhosis: New thoughts on pathophysiology and treatment

   • Andrew Mason
   • Sateesh Nair

   OriginalPaper Pages: 45 - 51

10. Treatment of hepatitis B and C following liver transplantation

    • Craig A. Sponseller
    • Sanjay Ramrakhiani

    OriginalPaper Pages: 52 - 62

11. How will we use the new antiviral agents for hepatitis B?

    • Robert P. Perrillo

    OriginalPaper Pages: 63 - 71

12. The role of endoscopic ultrasound in hepatobiliary disease

    • David A. Schwartz
    • Maurits J. Wiersema

    OriginalPaper Pages: 72 - 78

13. The impact of liver disease on health-related quality of life: A review of the literature

    • Lisa M. Martin
    • Michael J. Sheridan
    • Zobair M. Younossi

    OriginalPaper Pages: 79 - 83

14. Recent advances in pediatric liver transplantation

    • Debora Kogan-Liberman
    • Sukru Emre
    • Benjamin L. Shneider

    OriginalPaper Pages: 84 - 97